| Aug 14, 2013
| 10:10 PM
NEW YORK (Reuters) - Kurt is a 32-year-old IT systems administrator from Des Moines, Iowa. He has a colleague who had been prescribed "ridiculous amounts" of Vicodin for a chronic back problem.
His colleague offered him some of the pills. Soon Kurt was...
| May 15, 2013
| 3:57 PM
LOS ANGELES (Reuters) - After decades of using one-size-fits-all therapies to combat cancer, doctors are using new tools to help decide when their patients can skip chemotherapy or other harsh treatments.
An approach to oncology that has been in place...
| Nov 13, 2012
| 11:03 PM
LONDON (Reuters) - Diabetes is running at record levels worldwide and half the people estimated to have the disease are, as yet, undiagnosed, according to a report on Wednesday.
The number of people living with diabetes is now put at 371 million, up from...
| Apr 24, 2013
With a federal judge clearing away age restrictions on purchasing emergency contraception, many Chicago-area health care providers, teens and others are preparing for more accessibility — even if they're not exactly sure how the drug will be made...
| Sep 13, 2011
| 4:41 AM
LONDON (Reuters) - The number of people living with diabetes has soared to 366 million, and the disease kills one person every seven seconds, posing a "massive challenge" to healthcare systems worldwide, experts said on Tuesday.
The vast majority of...
| Feb 7, 2011
| 3:49 PM
A new study finds that one the fastest-growing classes of prescription drugs in the United States is linked to shrinkage in the brains of those who take it, raising some new questions about the widening use of antipsychotic medications.
| Feb 28, 2012
| 5:13 PM
A new study suggests that the 6% to 10% of Americans who use prescription sleep medications such as zolpidem (Ambien), temazepam (Restoril), eszopiclone (Lunesta) and zaleplon (Sonata) are more likely to develop cancer, and far more likely to die...
| Nov 29, 2011
| 4:22 PM
The nation's largest-selling pharmaceutical is going generic this week. Lipitor, which is prescribed to help people reduce their cholesterol levels, is going "off-patent" Wednesday. According to a HealthDay News report, Lipitor sales were nearly $4...
| Jan 8, 2011
Although first approved to treat schizophrenia, new antipsychotic medications are increasingly being prescribed for a host of other uses, even when there is little evidence they work, U.S. researchers said on Friday.
The drugs, known as "atypical...
| Feb 7, 2011
| 8:41 PM
WASHINGTON (AP) -- GlaxoSmithKline PLC said Monday it has updated the labeling of its diabetes pill Avandia to include safety restrictions ordered by federal health authorities because of the drug's links to heart attack.
The Food and Drug Administration...
| Dec 8, 2009
In a study that may be reassuring to older men taking testosterone in hopes of combating the aging process, Dutch researchers have reported that the hormone supplements did not cause any ill effects in healthy men.
Tens of thousands of American men are...